GMO Quality Fund VI (GQLOX)
33.00
0.00 (0.00%)
USD |
Mar 25 2025
Key Stats
Customize
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| -- | -- | -- | -- |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| -- | -- | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks total return. The Fund seeks to achieve its objective by investing its assets in equities of companies that GMO believes to be of high quality. The Fund may invest in U.S. Treasury Fund, in money market funds unaffiliated with GMO, and directly in the types of investments held by money market funds. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US |
| Peer Group | Large-Cap Core Funds |
| Global Macro | Equity North America |
| US Macro | Large-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Growth & Income Funds |
| Fund Owner Firm Name | GMO |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
--
--
Peer Group Low
--
Peer Group High
1 Year
% Rank:
--
--
Peer Group Low
--
Peer Group High
3 Months
% Rank:
--
--
Peer Group Low
--
Peer Group High
3 Years
% Rank:
--
--
Peer Group Low
--
Peer Group High
6 Months
% Rank:
--
--
Peer Group Low
--
Peer Group High
5 Years
% Rank:
--
--
Peer Group Low
--
Peer Group High
YTD
% Rank:
--
--
Peer Group Low
--
Peer Group High
10 Years
% Rank:
--
--
Peer Group Low
--
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of March 26, 2025.
Asset Allocation
As of November 30, 2024.
| Type | % Net |
|---|---|
| Cash | 0.08% |
| Stock | 99.39% |
| Bond | 0.54% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 0.00% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Microsoft Corp | 5.96% | 395.16 | 0.53% |
| Apple Inc | 5.18% | 223.75 | 1.37% |
| Meta Platforms Inc | 4.32% | 626.31 | 1.21% |
| Alphabet Inc | 4.18% | 170.56 | 1.72% |
| Oracle Corp | 3.84% | 153.93 | -0.61% |
| UnitedHealth Group Inc | 3.66% | 513.43 | -0.59% |
| Visa Inc | 3.28% | 344.62 | 0.22% |
| Johnson & Johnson | 3.24% | 161.02 | -1.39% |
| Abbott Laboratories | 3.23% | 125.60 | -1.27% |
| Taiwan Semiconductor Manufacturing Co Ltd | 3.11% | 17.24 | 0.00% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | 0.38% |
| Administration Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product | -- |
| Available for RRSP | -- |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 300.00M None |
| Minimum Subsequent Investment | 0.00 None |
Basic Info
| Investment Strategy | |
| The Fund seeks total return. The Fund seeks to achieve its objective by investing its assets in equities of companies that GMO believes to be of high quality. The Fund may invest in U.S. Treasury Fund, in money market funds unaffiliated with GMO, and directly in the types of investments held by money market funds. |
| General | |
| Security Type | Mutual Fund |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US |
| Peer Group | Large-Cap Core Funds |
| Global Macro | Equity North America |
| US Macro | Large-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Growth & Income Funds |
| Fund Owner Firm Name | GMO |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM | -- |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| ROI (TTM) | -- |
| Return on Investment (TTM) | -- |
| Earning Yield | -- |
| LT Debt / Shareholders Equity | -- |
Growth Metrics
| EPS Growth (1Y) | 16.11% |
| EPS Growth (3Y) | 14.65% |
| EPS Growth (5Y) | 10.05% |
| Sales Growth (1Y) | 6.63% |
| Sales Growth (3Y) | 11.10% |
| Sales Growth (5Y) | 9.47% |
| Sales per Share Growth (1Y) | 8.08% |
| Sales per Share Growth (3Y) | 12.66% |
| Operating Cash Flow - Growth Ratge (3Y) | 7.93% |
As of November 30, 2024
Fund Details
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:GQLOX", "name") |
| Broad Asset Class: =YCI("M:GQLOX", "broad_asset_class") |
| Broad Category: =YCI("M:GQLOX", "broad_category_group") |
| Prospectus Objective: =YCI("M:GQLOX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |